9-Oxabicyclo[6.2.1]undeca-1,5-dien-10-one,2-[(acetyloxy)methyl]-11-(1,5-dimethyl-4-hexenyl)-6-methyl- (9CI) (116406-17-8)

Identification
Name:	9-Oxabicyclo[6.2.1]undeca-1,5-dien-10-one,2-[(acetyloxy)methyl]-11-(1,5-dimethyl-4-hexenyl)-6-methyl- (9CI)
Synonyms:	DictyotalideB
CAS:	116406-17-8
Molecular Formula:	C22H32 O4
Molecular Weight:	360.4871
InChI:	InChI=1/C22H32O4/c1-14(2)8-6-10-16(4)20-19-12-15(3)9-7-11-18(13-25-17(5)23)21(20)22(24)26-19/h8-9,16,19-20H,6-7,10-13H2,1-5H3/b15-9-,21-18-
Molecular Structure:
Properties
Flash Point:	243.9°C
Boiling Point:	494.9°C at 760 mmHg
Density:	1.06g/cm³
Refractive index:	1.514
Flash Point:	243.9°C
Safety Data

Other Product

9-Oxabicyclo[6.2.1]undec-5-en-10-one,2-[(acetyloxy)methylene]-11-[(1R)-1,5-dimethyl-4-hexenyl]-6-methyl-,(1R,2Z,5E,8R,11S)-rel-(-)- (9CI)
9-Oxabicyclo[6.2.1]undec-5-ene-2-carboxaldehyde,11-(1,5-dimethyl-4-hexenyl)-6-methyl-10-oxo- (9CI)
9-Oxabicyclo[6.2.1]undec-5-ene-2,10-dione,11-(1,5-dimethyl-4-hexenyl)-6-methyl- (9CI)
Bicyclo[7.2.0]undeca-1(9),4-dien-10-one,11- (acetyloxy)-8-[(1R)-1,5-dimethyl-4-hexenyl]- 5-methyl-,(4E,8S,11S)-
11-Oxabicyclo[6.2.1]undecan-3-one,1-methyl-7-methylene-4-(1-methylethyl)- (9CI)
10-Oxabicyclo[7.2.1]dodeca-1(12),5-dien-11-one,4-(acetyloxy)-5-methyl-8-(1-methylethenyl)-, (4S,5E,8S,9R)- (9CI)
1-[10-chloro-6-(10-chloro-2-oxabicyclo[5.4.0]undeca-8,10,12-trien-5-yl )-2-oxabicyclo[5.4.0]undeca-8,10,12-trien-6-yl]-4-methyl-piperazine di hydrochloride
Spiro[5.5]undeca-7,9-dien-1-one, 9-ethoxy-11-methyl- (9CI)
4,8-Dimethyl-1-isopropyl-2-(4-methoxybenzoyloxy)-11-oxabicyclo[6.2.1]undec-3-ene
11-Oxabicyclo[6.2.1]undecane-2,10-diol,1- methyl-7-methylene-4-(1-methylethenyl)-
Spiro[5.5]undeca-7,9-dien-1-one,5-methyl-
(1R,2S)-1-(4-hydroxyphenyl)-2-methyl-3-azaspiro[5.5]undeca-7,10-dien-9-one hydrochloride
Spiro[4.6]undeca-2,10-dien-6-one,11-methyl-8-(1-methylethenyl)-, (8R)-
(+)-(2S,6Z,9S,10E)-9-{[tert-Butyl(dimethyl)silyl]oxy}-2,6,10-trimethyl-11-(2-methyl-1,3-thiazol-4-yl)-undeca-6,10-dien-1-ol
2-Oxabicyclo[2.2.2]octan-3-one,7-[(4b,17a)-4-(acetyloxy)-14,17-dihydroxy-1-oxoandrosta-2,5-dien-17-yl]-5-hydroxy-4,5-dimethyl-,(1R,4R,5R,7R)- (9CI)
Benzoic acid,2,4-dihydroxy-6-methyl-,(1'R,2'aR,4'R,4'aR,7R,7'S,9'aR,9'bR,11'aR)-3-[(1E)-2-carboxyethenyl]-1',2',2'a,3',4'a,6',7,7',8,8',9',9'a,9'b,10',11',11'a-hexadecahydro-7'-hydroxy-7,9'a,11'a-trimethyl-6,8-dioxo-1'-[(1R,2E,4R)-1,4,5-trimethyl-2-hexenyl]spiro[1H-2-benzopyran-5(6H),4'-[4H]indeno[6,7,1-mna]anthracen]-7-ylester (9CI)
(2S,6Z,9S,10E)-9-((tert-butyldimethylsilyl)oxy)-2,10-dimethyl-11-(2-methylthiazol-4-yl)undeca-6,10-dien-1-ol
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-(1-ethenyl-4-hydroxy-1,5-dimethyl-5-hexenyl)-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-(9CI)
10-Oxabicyclo[7.2.1]dodec-5-en-11-one,4-hydroxy-5-methyl-8-(1-methylethenyl)-, (1R,4S,5E,8R,9R)- (9CI)
2-Butenoic acid,2-methyl-,4-(acetyloxy)-6,10-dimethyl-3-(1-methylethyl)-11-oxabicyclo[8.1.0]undec-6-en-2-ylester (9CI)